![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | MINDY1 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Mindy1 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MINDY1 mRNA | CTD | PMID:22206623 | MINDY1 | Human | 1,2-dimethylhydrazine | affects expression | ISO | Mindy1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine affects the expression of MINDY1 mRNA | CTD | PMID:22206623 | MINDY1 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of MINDY1 mRNA | CTD | PMID:30165855 | MINDY1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Mindy1 (Mus musculus) | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of MINDY1 mRNA | CTD | PMID:25975270 | MINDY1 | Human | 2-hydroxypropanoic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of MINDY1 mRNA | CTD | PMID:30851411 | MINDY1 | Human | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of MINDY1 protein | CTD | PMID:34186270 | MINDY1 | Human | 4-hydroxyphenyl retinamide | increases expression | ISO | Mindy1 (Mus musculus) | 6480464 | Fenretinide results in increased expression of MINDY1 mRNA | CTD | PMID:28973697 | MINDY1 | Human | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of MINDY1 mRNA | CTD | PMID:32763439 | MINDY1 | Human | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of MINDY1 mRNA | CTD | PMID:23724009 | MINDY1 | Human | amphetamine | increases expression | ISO | Mindy1 (Rattus norvegicus) | 6480464 | Amphetamine results in increased expression of MINDY1 mRNA | CTD | PMID:30779732 | MINDY1 | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of MINDY1 mRNA | CTD | PMID:33212167 | MINDY1 | Human | arsane | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of MINDY1 mRNA | CTD | PMID:32525701 | MINDY1 | Human | arsenic atom | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of MINDY1 mRNA | CTD | PMID:32525701 | MINDY1 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of MINDY1 3' UTR and Benzo(a)pyrene results in increased methylation of MINDY1 5' UTR | CTD | PMID:27901495 | MINDY1 | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MINDY1 mRNA and bisphenol A results in increased expression of MINDY1 protein | CTD | PMID:25047013 and PMID:34186270 | MINDY1 | Human | bisphenol A | decreases expression | ISO | Mindy1 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of MINDY1 mRNA | CTD | PMID:30816183 more ... | MINDY1 | Human | bisphenol A | affects expression | ISO | Mindy1 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of MINDY1 mRNA | CTD | PMID:25181051 | MINDY1 | Human | bisphenol F | increases expression | EXP | | 6480464 | bisphenol F results in increased expression of MINDY1 protein | CTD | PMID:34186270 | MINDY1 | Human | cadmium atom | decreases expression | EXP | | 6480464 | Cadmium results in decreased expression of MINDY1 mRNA | CTD | PMID:23369406 | MINDY1 | Human | caffeine | increases phosphorylation | EXP | | 6480464 | Caffeine results in increased phosphorylation of MINDY1 protein | CTD | PMID:35688186 | MINDY1 | Human | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of MINDY1 mRNA | CTD | PMID:27392435 | MINDY1 | Human | clofibrate | decreases expression | ISO | Mindy1 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of MINDY1 mRNA | CTD | PMID:17585979 | MINDY1 | Human | copper(II) chloride | decreases expression | EXP | | 6480464 | cupric chloride results in decreased expression of MINDY1 mRNA | CTD | PMID:38568856 | MINDY1 | Human | crocidolite asbestos | decreases expression | ISO | Mindy1 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of MINDY1 mRNA | CTD | PMID:29279043 | MINDY1 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of MINDY1 mRNA | CTD | PMID:20106945 | MINDY1 | Human | DDE | decreases expression | EXP | | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased expression of MINDY1 mRNA | CTD | PMID:38568856 | MINDY1 | Human | dibutyl phthalate | increases expression | ISO | Mindy1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of MINDY1 mRNA | CTD | PMID:21266533 | MINDY1 | Human | fenthion | decreases expression | ISO | Mindy1 (Mus musculus) | 6480464 | Fenthion results in decreased expression of MINDY1 mRNA | CTD | PMID:34813904 | MINDY1 | Human | flutamide | increases expression | ISO | Mindy1 (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of MINDY1 mRNA | CTD | PMID:24136188 | MINDY1 | Human | folic acid | multiple interactions | ISO | Mindy1 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MINDY1 mRNA | CTD | PMID:22206623 | MINDY1 | Human | folic acid | decreases expression | ISO | Mindy1 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of MINDY1 mRNA | CTD | PMID:25629700 | MINDY1 | Human | folpet | increases expression | ISO | Mindy1 (Mus musculus) | 6480464 | folpet results in increased expression of MINDY1 mRNA | CTD | PMID:31558096 | MINDY1 | Human | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of MINDY1 mRNA | CTD | PMID:23649840 | MINDY1 | Human | FR900359 | decreases phosphorylation | EXP | | 6480464 | FR900359 results in decreased phosphorylation of MINDY1 protein | CTD | PMID:37730182 | MINDY1 | Human | gentamycin | decreases expression | ISO | Mindy1 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of MINDY1 mRNA | CTD | PMID:33387578 | MINDY1 | Human | hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of MINDY1 mRNA | CTD | PMID:20044591 | MINDY1 | Human | leflunomide | decreases expression | EXP | | 6480464 | leflunomide results in decreased expression of MINDY1 mRNA | CTD | PMID:28988120 | MINDY1 | Human | menadione | affects expression | EXP | | 6480464 | Vitamin K 3 affects the expression of MINDY1 mRNA | CTD | PMID:20044591 | MINDY1 | Human | methidathion | decreases expression | ISO | Mindy1 (Mus musculus) | 6480464 | methidathion results in decreased expression of MINDY1 mRNA | CTD | PMID:34813904 | MINDY1 | Human | methotrexate | increases expression | EXP | | 6480464 | Methotrexate results in increased expression of MINDY1 mRNA | CTD | PMID:17400583 | MINDY1 | Human | nitrates | multiple interactions | ISO | Mindy1 (Mus musculus) | 6480464 | [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MINDY1 mRNA | CTD | PMID:35964746 | MINDY1 | Human | paracetamol | decreases expression | ISO | Mindy1 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of MINDY1 mRNA | CTD | PMID:33387578 | MINDY1 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of MINDY1 mRNA | CTD | PMID:29067470 | MINDY1 | Human | perfluorononanoic acid | decreases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of MINDY1 mRNA | CTD | PMID:32588087 | MINDY1 | Human | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MINDY1 mRNA | CTD | PMID:19710929 | MINDY1 | Human | pirinixic acid | increases expression | ISO | Mindy1 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of MINDY1 mRNA | CTD | PMID:23811191 | MINDY1 | Human | pirinixic acid | multiple interactions | ISO | Mindy1 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of MINDY1 mRNA | CTD | PMID:19710929 | MINDY1 | Human | rac-lactic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of MINDY1 mRNA | CTD | PMID:30851411 | MINDY1 | Human | sodium arsenate | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of MINDY1 mRNA | CTD | PMID:32525701 | MINDY1 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of MINDY1 mRNA | CTD | PMID:38568856 | MINDY1 | Human | sodium dichromate | increases expression | ISO | Mindy1 (Mus musculus) | 6480464 | sodium bichromate results in increased expression of MINDY1 mRNA | CTD | PMID:31558096 | MINDY1 | Human | sulforaphane | decreases expression | EXP | | 6480464 | sulforaphane results in decreased expression of MINDY1 mRNA | CTD | PMID:31838189 | MINDY1 | Human | thiram | decreases expression | EXP | | 6480464 | Thiram results in decreased expression of MINDY1 mRNA | CTD | PMID:38568856 | MINDY1 | Human | titanium dioxide | decreases methylation | ISO | Mindy1 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of FAM63A gene | CTD | PMID:35295148 | MINDY1 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of MINDY1 mRNA | CTD | PMID:37042841 | MINDY1 | Human | triptonide | affects expression | ISO | Mindy1 (Mus musculus) | 6480464 | triptonide affects the expression of MINDY1 mRNA | CTD | PMID:33045310 | MINDY1 | Human | tris(2-butoxyethyl) phosphate | affects expression | EXP | | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of MINDY1 mRNA | CTD | PMID:29024780 | MINDY1 | Human | tungsten | decreases expression | ISO | Mindy1 (Mus musculus) | 6480464 | Tungsten results in decreased expression of MINDY1 mRNA | CTD | PMID:30912803 | MINDY1 | Human | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of MINDY1 mRNA | CTD | PMID:28818685 | MINDY1 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of MINDY1 mRNA | CTD | PMID:29154799 | |